Back to Screener

Healthcare

Blueprint Medicines Corporation(BPMC)

Live Price

Offline

$129.46

+0.14% today

Window Change

+0.83%

Window

Jun 23, 2025 โ†’ Jul 18, 2025

Market Cap
$8.36B
Revenue Growth
+104.0%
EPS Growth
+87.2%
Dividend Yield
0.0%
Sparse coverage

Historical coverage is still filling in

This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.

Coverage: 19 bars ยท Jun 23, 2025 โ†’ Jul 18, 2025

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Blueprint Medicines Corporation (BPMC) is a Healthcare stock with a market cap of $8.36B. The stock last traded around $129.46 and up 0.8% across the available one-year price window (Jun 23, 2025 โ†’ Jul 18, 2025). Baseline metrics include revenue growth of +104.0%, EPS growth of +87.2%, a dividend yield of 0.0%. What stands out right now is revenue +104.0%, EPS +87.2%, free cash flow +56.5% with operating margin -27.8% and ROIC -8.2%. Valuation already assumes a fairly strong business story at price/sales 28.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines BPMC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+104.0% vs +7.6% peer median

Operating Margin

Below sector median

-27.8% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report came in below the EPS bar

2025 was reported on May 1, 2025 with an EPS surprise of -76.2% and a revenue surprise of -13.5%.

The operating story is still moving forward

Revenue is running at +104.0% and EPS at +87.2%, with operating margin around -27.8%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

BPMC

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

BPMC Max Drawdown

-0.23%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BPMC and SPY.

Calendar-year return history is still loading or unavailable.
BL

Company Overview

Blueprint Medicines Corporation

Last Updated
May 7, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
28.3
Price/Book
24.1

Growth

Revenue
+104.0%
EPS
+87.2%
Free Cash Flow
+56.5%

Profitability

Gross Margin
96.5%
Operating Margin
-27.8%
Net Margin
-16.7%
ROE
-15.4%
ROIC
-8.2%

Balance Sheet

Debt/Equity
0.36
Current Ratio
2.80

Earnings Reports

๐Ÿ“… Last reportedMay 1, 2025
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 1, 25
โœ—
-0.74
Est -0.42
-76.2%
149413.0B
Est 172804.4B
-13.5%
โ€”
Feb 13, 25
โœ—
-0.79
Est -0.68
-16.2%
146366.0B
Est 158443.4B
-7.6%
โ€”
Oct 30, 24
โœ“
-0.89
Est -0.97
+8.3%
128184.0B
Est 146600.0B
-12.6%
โ€”
Aug 1, 24
โœ“
-0.80
Est -1.28
+37.5%
138157.0B
Est 103570.0B
+33.4%
โ€”
May 2, 24
โœ“
-1.32
Est -1.64
+19.5%
96116.0B
Est 80430.0B
+19.5%
โ€”
Feb 15, 24
โœ“
-1.82
Est -2.04
+10.8%
71957.0B
Est 66800.0B
+7.7%
โ€”
Oct 26, 23
โœ“
-2.20
Est -2.39
+8.0%
56566.0B
Est 50400.0B
+12.2%
โ€”
Aug 2, 23
โœ“
-2.19
Est -2.58
+15.1%
57570.0B
Est 45470.0B
+26.6%
โ€”
May 4, 23
โœ“
-2.15
Est -2.66
+19.2%
63287.0B
Est 41960.0B
+50.8%
โ€”
Feb 16, 23
โœ“
-2.65
Est -2.73
+2.9%
38781.0B
Est 34100.5B
+13.7%
โ€”
Nov 1, 22
โœ“
-2.23
Est -2.51
+11.2%
65977.0B
Est 43509.5B
+51.6%
โ€”
Aug 2, 22
โœ—
-2.68
Est -2.23
-20.2%
36547.0B
Est 37283.1B
-2.0%
โ€”
May 3, 22
โ€”
-1.79
Est -1.79
0.0%
62731.0B
Est 40091.0B
+56.5%
โ€”
Feb 16, 22
โœ—
-0.99
Est -0.71
-39.4%
107022.0B
Est 103648.8B
+3.3%
โ€”
Oct 28, 21
โœ—
-2.00
Est -1.69
-18.3%
24188.0B
Est 44170.0B
-45.2%
โ€”
Jul 29, 21
โœ—
-1.86
Est -1.77
-5.1%
27295.0B
Est 27295.0B
0.0%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks